Evaluating iron deposition in gray matter nuclei of patients with acute ischemic stroke using quantitative susceptibility mapping

被引:0
|
作者
Zhou, Li [1 ]
Yang, Jie [1 ]
Zhang, Wei [1 ]
Han, Limei [1 ]
Zhou, Shenghai [1 ]
Zheng, Chunyan [1 ]
Feng, Hao [1 ]
Zhong, Jianquan [1 ]
机构
[1] Zigong First Peoples Hosp, Dept Radiol, Zigong, Sichuan, Peoples R China
来源
FRONTIERS IN NEUROLOGY | 2024年 / 15卷
关键词
acute ischemic stroke; brain iron; quantitative susceptibility mapping; gray matter nuclei; caudate nucleus; putamen; IMAGING BIOMARKERS; SUBSTANTIA-NIGRA; BRAIN IRON; NEURODEGENERATION;
D O I
10.3389/fneur.2024.1518911
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objectives: Understanding the microscopic pathophysiological mechanisms underlying acute ischemic stroke (AIS) is vital for facilitating early clinical diagnosis and intervention. In this study, we aimed to quantitatively assess brain iron changes in gray matter (GM) nuclei in patients with AIS via quantitative susceptibility mapping (QSM). Methods: Thirty-four patients with AIS and thirty age-and sex-matched healthy controls (HCs) were included. QSM and conventional magnetic resonance imaging were performed. Intergroup differences in regional susceptibility values were calculated for the bilateral caudate nucleus (CN), globus pallidus (GP), putamen (PUT), red nucleus (RN), substantia nigra (SN), thalamus (THA), and dentate nucleus (DN). A receiver operating characteristic curve was plotted to evaluate the classification and diagnostic performance of susceptibility values in distinguishing patients with AIS from HCs. Multiple linear regression analysis was used to investigate the impact of clinical variables on susceptibility values. Correlation analysis was used to assess the correlation between regional iron variations and clinical scores. A paired t test was used to calculate the differences in susceptibility values between the bilateral hemispheres in the participants. Results: Compared with the HCs, the patients with AIS had significantly increased susceptibility values in the bilateral CN and PUT (p < 0.05, FDR correction). The highest diagnostic performance was observed in the combination of susceptibility values with differences between groups (AUC = 0.722). Multiple linear regression analysis revealed that increased susceptibility in the right CN was significantly associated with smoking (p < 0.05). The susceptibility values were not significantly correlated with the clinical scores (p > 0.05), but age was positively correlated with the modified Rankin Scale scores at admission (p < 0.05). The susceptibility values of the SN exhibited lateral asymmetry in patients with AIS. Conclusion: This study revealed increased iron concentrations in the GM nuclei of patients with AIS. Iron deposition in GM nuclei may be a potential biomarker for further understanding the pathophysiological mechanism underlying AIS.
引用
收藏
页数:9
相关论文
共 50 条
  • [31] Spatiotemporal variations of magnetic susceptibility in the deep gray matter nuclei from 1 month to 6 years: A quantitative susceptibility mapping study
    Ning, Ning
    Liu, Congcong
    Wu, Peng
    Hu, Yajie
    Zhang, Weishan
    Zhang, Lei
    Li, Mengxuan
    Gho, Sung-Min
    Kim, Dong-Hyun
    Guo, Hua
    Yang, Jian
    Jin, Chao
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2019, 49 (06) : 1600 - 1609
  • [32] Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease
    Zhao, Weiwei
    Yang, Chunhui
    Tong, Rui
    Chen, Luguang
    Chen, Mengying
    Gillen, Kelly M.
    Li, Gaiying
    Ma, Chao
    Wang, Yi
    Wu, Xi
    Li, Jianqi
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (02) : 581 - 590
  • [33] Iron deposition in Parkinson's disease by quantitative susceptibility mapping
    Chen, Qiqi
    Chen, Yiting
    Zhang, Yue
    Wang, Furu
    Yu, Hongchang
    Zhang, Caiyuan
    Jian, Zhen
    Luo, Weifeng
    BMC NEUROSCIENCE, 2019, 20 (1)
  • [34] Iron deposition in Parkinson’s disease by quantitative susceptibility mapping
    Qiqi Chen
    Yiting Chen
    Yue Zhang
    Furu Wang
    Hongchang Yu
    Caiyuan Zhang
    Zhen Jiang
    Weifeng Luo
    BMC Neuroscience, 20
  • [35] Gray matter atrophy in patients with ischemic stroke with cognitive impairment
    Stebbins, Glenn T.
    Nyenhuis, David L.
    Wang, Changsheng
    Cox, Jennifer L.
    Freels, Sally
    Bangen, Katherine
    DeToledo-Morrell, Leyla
    Sripathirathan, Kumar
    Moseley, Michael
    Turner, David A.
    Gabrieli, John D. E.
    Gorelick, Philip B.
    STROKE, 2008, 39 (03) : 785 - 793
  • [36] Evaluation of iron deposition in brain basal ganglia of patients with Parkinson's disease using quantitative susceptibility mapping
    Shahmaei, Vahid
    Faeghi, Fariborz
    Mohammdbeigi, Ahmad
    Hashemi, Hasan
    Ashrafi, Farzad
    EUROPEAN JOURNAL OF RADIOLOGY OPEN, 2019, 6 : 169 - 174
  • [37] Editorial for "The Relationship Between Iron Distribution in Deep Gray Matter Nuclei Measured by Quantitative Susceptibility Mapping and Motor Outcome After Deep Brain Stimulation in Patients With Parkinson's Disease"
    Gobbi, David G.
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2023, 58 (02) : 591 - 592
  • [38] Quantitative T2′-Mapping in Acute Ischemic Stroke
    Bauer, Sonja
    Wagner, Marlies
    Seiler, Alexander
    Hattingen, Elke
    Deichmann, Ralf
    Noeth, Ulrike
    Singer, Oliver C.
    STROKE, 2014, 45 (11) : 3280 - 3286
  • [39] Assessing Global and Regional Iron Content in Deep Gray Matter as a Function of Age Using Susceptibility Mapping
    Liu, Manju
    Liu, Saifeng
    Ghassaban, Kiarash
    Zheng, Weili
    Dicicco, Dane
    Miao, Yanwei
    Habib, Charbel
    Jazmati, Tarek
    Haacke, E. Mark
    JOURNAL OF MAGNETIC RESONANCE IMAGING, 2016, 44 (01) : 59 - 71
  • [40] The Value of Susceptibility-Weighted Imaging (SWI) in Evaluating the Ischemic Penumbra of Patients with Acute Cerebral Ischemic Stroke
    Wang, Yong-Ren
    Li, Zhao-Sheng
    Huang, Wei
    Yang, Hui-Qiang
    Gao, Bo
    Chen, Yu-Ting
    NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2021, 17 : 1745 - 1750